Question 1

What is Aquestive Therapeutics?

Accepted Answer

Aquestive Therapeutics is a Company.

Question 2

How often does Aquestive Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 66 articles.

Question 3

When was Aquestive Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Feb 04, 2026.

Question 4

When was Aquestive Therapeutics last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Aquestive Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: -25 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Aquestive Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Aquestive Therapeutics?

Accepted Answer

Aquestive Therapeutics Securities Fraud Lawsuits (Apr 01, 2026, 60 articles).

Question 8

Who is Aquestive Therapeutics most connected to?

Accepted Answer

Top relationships: United States — Food and Drug Administration, United States — Food and Drug Administration.

Question 9

How did the "Aquestive Therapeutics Securities Fraud Lawsuits" event impact Aquestive Therapeutics?

Accepted Answer

Aquestive Therapeutics is the defendant in a class action lawsuit for allegedly making false and misleading statements regarding its New Drug Application for Anaphylm, leading to a significant drop in its stock price.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.